:: CLDF ::

Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience

Medicina (Kaunas). 2024 Nov 12;60(11):1854.doi: 10.3390/medicina60111854.

Giuseppe Guido Maria Scarlata¹, Abdulrahman Ismaiel², Maria Luisa Gambardella¹, Daniel Corneliu Leucuta³, Francesco Luzza¹, Dan Lucian Dumitrascu², Ludovico Abenavoli¹

Predictive value of renal shear wave elastography in liver cirrhosis

Dig Liver Dis. 2024 Oct 26:S1590-8658(24)01062-4. doi: 10.1016/j.dld.2024.10.018.Online ahead of print.

Christian Hagel¹, Michael Hirth¹, Jan Bißbort¹, Andreas Teufel², Svetlana Hetjens³, Matthias P Ebert¹, Christoph Antoni⁴

Predictive value of renal shear wave elastography in liver cirrhosis

Dig Liver Dis. 2024 Oct 26:S1590-8658(24)01062-4. doi: 10.1016/j.dld.2024.10.018.Online ahead of print.

Christian Hagel¹, Michael Hirth¹, Jan Bißbort¹, Andreas Teufel², Svetlana Hetjens³, Matthias P Ebert¹, Christoph Antoni⁴

Association of HRS-AKI with Mortality in Patients with Cirrhosis Requiring Renal Replacement Therapy: Results from the HRS-HARMONY Consortium

Kidney360. 2024 Sep 30. doi: 10.34067/KID.0000000589. Online ahead of print.

Augusto Cama-Olivares¹, Tianqi Ouyang², Tomonori Takeuchi¹³, Shelsea A St Hillien², Jevon E Robinson², Raymond T Chung⁴, Giuseppe Cullaro⁵, Constantine J Karvellas⁶, Josh Levitsky⁷⁸, Eric S Orman⁹, Kavish R Patidar¹⁰, Kevin R Regner¹¹, Danielle L Saly², Deirdre Sawinski¹², Pratima Sharma¹³, J Pedro Teixeira¹⁴, Nneka N Ufere⁴, Juan Carlos Q Velez¹⁵, Hani M Wadei¹⁶, Nabeel Wahid⁸, Andrew S Allegretti², Javier A Neyra¹, Justin M Belcher¹⁷; HRS-HARMONY Consortium

Incidence and type of adverse events in patients with cirrhosis receiving terlipressin: A systematic review and meta-analysis

HepatolCommun. 2024Sep18;8(10):e0526.doi:10.1097/HC9.0000000000000526. eCollection 2024 Oct 1.

Yiyang Shang¹², Cai'e Wang¹², Huiyuan Lu¹², Lu Chai¹², Wentao Xu¹², Mauro Bernardi³, Xingshun Qi¹²

Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review

J Clin Transl Hepatol. 2024 Sep 28;12(9):780-791. doi: 10.14218/JCTH.2024.00188.Epub 2024 Jul 25.

Ahmed H Abdelwahed¹, Moataz Aboeldahb², George Y Wu¹

The Impact of Race and Sex on the Clinical Outcomes of Homeless Patients With Alcoholic Liver Disease: Propensity Score Matched Analysis of US Hospitals

J Clin Gastroenterol. 2024 Aug 1;58(7):708-717. doi: 10.1097/MCG.0000000000001919.

David U Lee¹, Jean Kwon², John Han², Kevin Chang², Sindhura Kolachana¹, Aneesh Bahadur², Ki Jung Lee², Gregory H Fan², Raza Malik³

Long-term continuous terlipressin infusion improves cardiac reserve in patients with decompensated cirrhosis

ClinGastroenterolHepatol. 2024Aug27:S15423565(24)00778X.doi:10.1016/j.cgh.2024.08.010. Online ahead of print.

Ryma Terbah¹, Anoop N Koshy², Avik Majumdar¹, Karl Vaz¹, Adam Testro¹, Marie Sinclair³

The Impact of Race and Sex on the Clinical Outcomes of Homeless Patients With Alcoholic Liver Disease: Propensity Score Matched Analysis of US Hospitals

J Clin Gastroenterol. 2024 Aug 1;58(7):708-717. doi: 10.1097/MCG.0000000000001919.

David U Lee¹, Jean Kwon², John Han², Kevin Chang², Sindhura Kolachana¹, Aneesh Bahadur², Ki Jung Lee², Gregory H Fan², Raza Malik³

10.

Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium

Aliment Pharmacol Ther. 2024 Jul 15. doi: 10.1111/apt.18159. Online ahead of print.

Ann T Ma¹, Andrew S Allegretti², Giuseppe Cullaro³, Tianqui Ouyang², Sumeet K Asrani⁴, Raymond T Chung⁵, Eric M Przybyszewski⁵, Robert M Wilechansky⁵, Jevon E Robinson², Pratima Sharma⁶, Douglas A Simonetto⁷, Prasun Jalal⁸, Eric S Orman⁹, Hani M Wadei¹⁰, Shelsea A St Hillien², Danielle Saly², Nneka N Ufere⁵, Leigh Anne Dageforde¹¹, Kevin R Regner¹², Justin M Belcher¹³¹⁴, Kavish R Patidar⁸¹⁵; from the HRS Harmony Consortium

11.

The Impact of Race and Sex on the Clinical Outcomes of Homeless Patients With Alcoholic Liver Disease: Propensity Score Matched Analysis of US Hospitals

J Clin Gastroenterol. 2024 Aug 1;58(7):708-717. doi: 10.1097/MCG.0000000000001919.

David U Lee¹, Jean Kwon², John Han², Kevin Chang², Sindhura Kolachana¹, Aneesh Bahadur², Ki Jung Lee², Gregory H Fan², Raza Malik³

12.

Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium

Aliment Pharmacol Ther. 2024 Jul 15. doi: 10.1111/apt.18159. Online ahead of print.

13.

Controversies in terlipressin and transplantation in the United States: How do we MELD the two?

Liver Transpl. 2024 Jul 1;30(7):753-759. doi: 10.1097/LVT.0000000000000370.Epub 2024 Mar 28.

Eric M Przybyszewski¹, Robert M Wilechansky¹, Paige McLean Diaz¹, Andrew S Allegretti², Lisa B VanWagner³, Giuseppe Cullaro⁴, Josh Levitsky⁵, Pere Ginès⁶⁷⁸, Salvatore Piano⁹, Sumeet K Asrani¹⁰, Kavish R Patidar¹¹; from the HRS-Harmony Consortium

14.

A Review of Terlipressin in Hepatorenal Syndrome: Targeting Endothelial Dysfunction and Subsequent Cardiovascular Adverse Events

Cardiol Rev. 2024 Jun 4. doi: 10.1097/CRD.0000000000000697. Online ahead of print.

Adrienne M Bielawski¹, William H Frishman²

15.

Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites

EurJGastroenterolHepatol. 2024Jun1;36(6):775783. doi:10.1097/MEG.0000000000002762.Epub 2024 Mar 19.

Georgios Kalambokis¹, Maria Christaki¹, Ilias Tsiakas¹, Grigorios Despotis¹, Lampros Lakkas², Spiridon Tsiouris³, Xanthi Xourgia³, Georgios S Markopoulos⁴, Lefkothea Dova⁴, Haralampos Milionis¹

16.

Management of hepatorenal syndrome and treatment-related adverse events

Curr Med Res Opin. 2024 May 21:1-14. doi: 10.1080/03007995.2024.2358242.Online ahead of print.

Lorenzo Peluso¹, Marzia Savi², Giacomo Coppalini², Deliana Veliaj², Nicola Villari², Giovanni Albano², Stephen Petrou³, Maria C Pace⁴, Marco Fiore⁴

17.

Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population

Liver Transpl. 2024 May 22. doi: 10.1097/LVT.0000000000000399. Online ahead of print.

K Rajender Reddy¹, Ethan M Weinberg¹, Stevan A Gonzalez², Manhal J Izzy³, Douglas A Simonetto⁴, R Todd Frederick⁵, Raymond A Rubin⁶, Zachary Fricker⁷, Jade Ikahihifo-Bender¹, Maggie Harte¹, Sandra Garcia², Kathryn Campbell³, Amy Olofson⁴, Ryan F Razavi⁵, Janelle M James⁶, Het Patel⁷, Grace Kim-Lee¹, Sherry Witkiewicz⁸, William Tobin⁸, Khurram Jamil⁹

18.

Long-Circulating Vasoactive 1,18-Octadecanedioic Acid-Terlipressin Conjugate

ACS

PharmacolTranslSci. 2024Apr30;7(5):12521261. doi:10.1021/acsptsci.3c00305.eCollection 2024 May 10.

Or Berger¹, Wonmin Choi¹, Caroline H Ko², Matthew P Thompson¹, Michael J Avram³⁴, Daniel J Scott⁵⁶, Bradley L Hoare⁵, Riley Cridge⁵, Mark Wheatley⁷⁸, Ross A D Bathgate⁵⁶, Daniel Batlle³⁹, Nathan C Gianneschi¹¹⁰¹¹¹²¹³^14 15

19.

Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2

Am J Physiol Gastrointest Liver Physiol. 2024 Mar 19. doi: 10.1152/ajpgi.00304.2023.Online ahead of print.

Eva Maria Schleicher¹, Simon Johannes Gairing¹, Darko Castven², Charlotte Sophie Hock¹, Henrike Dobbermann², Sophia Heinrich¹, Myriam Meineck¹, Leonard Kaps¹, Peter Robert Galle¹, Julia Weinmann-Menke³, Marc Nguyen-Tat¹, Jens Uwe Marquardt², Christian Labenz⁴

20.

Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis

J Hepatol. 2024 Mar 11:S0168-8278(24)00157-0. doi: 10.1016/j.jhep.2024.03.006.Online ahead of print.

Ann Thu Ma¹, Cristina Solé², Adrià Juanola³, Laia Escudé³, Laura Napoleone³, Emma Avitabile³, Martina Pérez-Guasch⁴, Marta Carol⁴, Enrico Pompili³, Jordi Gratacós-Ginés³, Anna Soria³, Ana Belén Rubio⁴, Marta Cervera⁴, Maria José Moreta³, Manuel Morales⁵, Elsa Solà⁶, Esteban Poch⁷, Núria Fabrellas⁸, Isabel Graupera⁴, Elisa Pose⁴, Pere Ginès⁹

21.

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial

Trials. 2024 Apr 16;25(1):265. doi: 10.1186/s13063-024-08063-3.

Vishal C Patel^#¹²³, Mark J McPhail^#⁴⁵, Ruhama Uddin^#⁴, Hassan Jafari⁶⁷, Vanessa Lawrence⁸, Clair Le Boutillier⁸⁹, James Shearer⁸, Nahel Yaziji⁸, Angela Cape⁷, Haroon Ahmed¹⁰, Christopher Ward¹¹, Peter Walsh¹², Kevin Besly⁴, Ane Zamalloa⁴, Joanna Kelly⁷; BOPPP study group; Ben Carter⁶⁷

Collaborators

BOPPP study group:

Ashis Mukhopadhya, Alicija Vileito, Tracy Henderson, Gwilym Webb, Jerrian Joyce Andrada, Abigail Ford, Cyril Sieberhagen, Claire Burston, Carol Brooks, Gavin Wright, Bushena Miyesa, Aimee Williams, Jay Patel, Melchizedek Penacerrada, Gautham Appanna, Gifthy Perez, Joanne Elliott, Keval Naik, Susan Smolen, Anna Beckwith, Matthew Foxton, Carina Bautista, Matthew Cramp, Ada Laureen Nweze, Gayatri Chakrabarty, Indhuja Rajkumar, Merlin James, Steven Masson, Sheenu Thomas, Lucy Dixon, Sarah Hogg, Louise Finlay, Kuldeep Cheent, Jessica Camp, Adrian Stanley, Alexis Duncan, Lauren Walker, Duncan Napier, Paula Hilltout, Linda Hill, Hiromi Uzu, Moby Joseph, Suzannah Pegler, Camille Walling, Lynsey Corless, Anisoara Kingsbury, Tania Nurun, Debasish Das, Anna Williams, Stephen Foley, Camelia Goodwin, Markus Gess, Margaret Grout, Ka-Kit Li, Olivia Watchorn, Laura Plummer, Laura Blackmore, Christos Tsintikidis, Allysha Perryman, George Bird, Emily Phiri, Mohamed Saleh, Adaze Woghiren, Dilukshi Wickramasinghe, Jodie Wright, Michael Miller, Shona Murray, Leanne Cosgrove, John Hutchinson, Julie Burton, Emma Stoner, Stephanie Lupton, Mayur Kumar, Nicola Griffiths, Anna Posada, Andrew Fowell, Avisnata Das, Jincy Daniel, Anu Rose Andrews, Dhiraj Tripathi, Emma Burke, Emma Eaves, Helen Emms, Dina Mansour, Ann Wilson, Maureen Armstrong, Rachael Swann, Faye McMeeken, Shona Perry, Naaventhan Palaniyappan, Elizabeth Davies, Kimberley Noon, Danielle Adebayo, Sarosh Khymani, Deepa Thapa, Mahesh Bhalme, Emma McKenna, Julie Chadwick, Jo Tod, Nina Barratt, Annamaria Wilce, Andrew Austin, Catherine Addleton, Ben Hudson, Rob James, Lily Zitter, Jane Hall, Jennifer Ryan, Christine Eastgate, Edward Britton, Martina Lofthouse, Vikram Sharma, James Hand, Louise Payaniandy, Paula Bravo, Marinos Pericleous, Sheila Mtuwa, Wisdom Mbama, Khaleel Jamil, Sumita Verma, Yaz Hassadin, Zhengmei He, Zdenka Cipinova, Roger McCorry, Allison Lloyd, Heather Lawther, Zeino Zeino, Lana Ward, Trudie Burge, Sarah Hughes, Joseph Delo, Criscel Jan Pelaez, David Whitley, Ameet Dhar, Nowlan Selvapatt, Maria Lanoria, Phil Berry, Sreelakshmi Kotha, Jessica Cordle, Ankita Sunny, Rohit Sinha, Louise Fairlie, Jennifer Henderson, Darren Craig, Eman Alabsawy, Julie Tregonning, Luke Summers, Sophy Booth, Esther Unitt, Susan Dale, Francisco Porras Perez, Melanie Kent, Suzanne Naylor,

22.

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis

Aliment Pharmacol Ther. 2024 Mar 25. doi: 10.1111/apt.17972. Online ahead of print.

Danielle Adebayo¹, Florence Wong²

23.

Acute kidney injury in patients with Cirrhosis: Acute disease quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus meeting

J Hepatol. 2024 Mar 23:S0168-8278(24)00214-9. doi: 10.1016/j.jhep.2024.03.031.Online ahead of print.

Mitra K Nadim¹, John A Kellum², Lui Forni³, Claire Francoz⁴, Sumeet K Asrani⁵, Marlies Ostermann⁶, Andrew S Allegretti⁷, Javier A Neyra⁸, Jody C Olson⁹, Salvatore Piano¹⁰, Lisa B VanWagner¹¹, Elizabeth C Verna¹², Ayse Akcan-Arikan¹³, Paolo Angeli¹⁴, Justin M Belcher¹⁵, Scott W Biggins¹⁶, Akash Deep¹⁷, Guadalupe Garcia-Tsao¹⁸, Yuri S Genyk¹⁹, Pere Gines²⁰, Patrick S Kamath²¹, Sandra L Kane-Gill²², Manish Kaushik²³, Nuttha Lumlertgul²⁴, Etienne Macedo²⁵, Rakhi Maiwall²⁶, Sebastian Marciano²⁷, Raimund H Pichler²⁸, Claudio Ronco²⁹, Puneeta Tandon³⁰, Juan-Carlos Q Velez³¹, Ravindra L Mehta³², François Durand³³

24.

Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2

Am J Physiol Gastrointest Liver Physiol. 2024 Mar 19. doi: 10.1152/ajpgi.00304.2023.Online ahead of print.

25.

Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis

J Hepatol. 2024 Mar 11:S0168-8278(24)00157-0. doi: 10.1016/j.jhep.2024.03.006.Online ahead of print.

Subscribe